AAPL vs. ABBV: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at AAPL and ABBV, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | AAPL | ABBV |
|---|---|---|
| Company Name | Apple Inc. | AbbVie Inc. |
| Country | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry | Technology Hardware, Storage & Peripherals | Biotechnology |
| Market Capitalization | 3,354.08 billion USD | 369.48 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | December 12, 1980 | January 2, 2013 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of AAPL and ABBV by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | AAPL | ABBV |
|---|---|---|
| 5-Day Price Return | -2.91% | 2.18% |
| 13-Week Price Return | 8.25% | 12.62% |
| 26-Week Price Return | -6.43% | 8.12% |
| 52-Week Price Return | 0.05% | 6.24% |
| Month-to-Date Return | 8.88% | 10.65% |
| Year-to-Date Return | -9.75% | 17.70% |
| 10-Day Avg. Volume | 61.85M | 4.64M |
| 3-Month Avg. Volume | 56.06M | 6.39M |
| 3-Month Volatility | 23.04% | 19.56% |
| Beta | 1.08 | 0.49 |
Profitability
Return on Equity (TTM)
AAPL
154.92%
Technology Hardware, Storage & Peripherals Industry
- Max
- 47.24%
- Q3
- 29.40%
- Median
- 9.11%
- Q1
- 6.06%
- Min
- -0.79%
AAPL’s Return on Equity of 154.92% is exceptionally high, placing it well beyond the typical range for the Technology Hardware, Storage & Peripherals industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.
ABBV
95.59%
Biotechnology Industry
- Max
- 77.14%
- Q3
- 10.76%
- Median
- -20.08%
- Q1
- -42.71%
- Min
- -119.20%
ABBV’s Return on Equity of 95.59% is exceptionally high, placing it well beyond the typical range for the Biotechnology industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.
Net Profit Margin (TTM)
AAPL
24.30%
Technology Hardware, Storage & Peripherals Industry
- Max
- 13.86%
- Q3
- 8.17%
- Median
- 4.62%
- Q1
- 3.65%
- Min
- -0.21%
AAPL’s Net Profit Margin of 24.30% is exceptionally high, placing it well beyond the typical range for the Technology Hardware, Storage & Peripherals industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.
ABBV
6.45%
Biotechnology Industry
- Max
- 59.44%
- Q3
- 16.21%
- Median
- -11.49%
- Q1
- -167.42%
- Min
- -409.07%
ABBV’s Net Profit Margin of 6.45% is aligned with the median group of its peers in the Biotechnology industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
AAPL
31.87%
Technology Hardware, Storage & Peripherals Industry
- Max
- 17.80%
- Q3
- 10.33%
- Median
- 6.31%
- Q1
- 4.86%
- Min
- 2.53%
AAPL’s Operating Profit Margin of 31.87% is exceptionally high, placing it well above the typical range for the Technology Hardware, Storage & Peripherals industry. This demonstrates outstanding efficiency in managing its core operations, which can be a result of strong pricing power or superior cost control.
ABBV
18.80%
Biotechnology Industry
- Max
- 60.62%
- Q3
- 20.76%
- Median
- -12.41%
- Q1
- -181.14%
- Min
- -482.02%
ABBV’s Operating Profit Margin of 18.80% is around the midpoint for the Biotechnology industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | AAPL | ABBV |
|---|---|---|
| Return on Equity (TTM) | 154.92% | 95.59% |
| Return on Assets (TTM) | 28.95% | 2.73% |
| Net Profit Margin (TTM) | 24.30% | 6.45% |
| Operating Profit Margin (TTM) | 31.87% | 18.80% |
| Gross Profit Margin (TTM) | 46.68% | 70.93% |
Financial Strength
Current Ratio (MRQ)
AAPL
0.87
Technology Hardware, Storage & Peripherals Industry
- Max
- 2.47
- Q3
- 1.98
- Median
- 1.40
- Q1
- 1.26
- Min
- 0.70
AAPL’s Current Ratio of 0.87 falls into the lower quartile for the Technology Hardware, Storage & Peripherals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
ABBV
0.74
Biotechnology Industry
- Max
- 19.31
- Q3
- 9.38
- Median
- 4.54
- Q1
- 2.45
- Min
- 0.76
ABBV’s Current Ratio of 0.74 is notably low, falling beneath the typical range for the Biotechnology industry. This suggests a heightened liquidity risk and could indicate potential challenges in meeting its short-term obligations.
Debt-to-Equity Ratio (MRQ)
AAPL
1.54
Technology Hardware, Storage & Peripherals Industry
- Max
- 1.47
- Q3
- 0.93
- Median
- 0.32
- Q1
- 0.19
- Min
- 0.00
With a Debt-to-Equity Ratio of 1.54, AAPL operates with exceptionally high leverage compared to the Technology Hardware, Storage & Peripherals industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.
ABBV
49.22
Biotechnology Industry
- Max
- 1.35
- Q3
- 0.64
- Median
- 0.09
- Q1
- 0.00
- Min
- 0.00
With a Debt-to-Equity Ratio of 49.22, ABBV operates with exceptionally high leverage compared to the Biotechnology industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.
Interest Coverage Ratio (TTM)
AAPL
622.51
Technology Hardware, Storage & Peripherals Industry
- Max
- 204.63
- Q3
- 90.22
- Median
- 21.70
- Q1
- 6.79
- Min
- -23.93
With an Interest Coverage Ratio of 622.51, AAPL demonstrates a superior capacity to service its debt, placing it well above the typical range for the Technology Hardware, Storage & Peripherals industry. This stems from either robust earnings or a conservative debt load.
ABBV
2.70
Biotechnology Industry
- Max
- 72.37
- Q3
- 1.91
- Median
- -7.81
- Q1
- -63.90
- Min
- -153.80
ABBV’s Interest Coverage Ratio of 2.70 is in the upper quartile for the Biotechnology industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.
Financial Strength at a Glance
| Symbol | AAPL | ABBV |
|---|---|---|
| Current Ratio (MRQ) | 0.87 | 0.74 |
| Quick Ratio (MRQ) | 0.83 | 0.48 |
| Debt-to-Equity Ratio (MRQ) | 1.54 | 49.22 |
| Interest Coverage Ratio (TTM) | 622.51 | 2.70 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
AAPL
0.46%
Technology Hardware, Storage & Peripherals Industry
- Max
- 4.50%
- Q3
- 3.66%
- Median
- 1.90%
- Q1
- 0.00%
- Min
- 0.00%
AAPL’s Dividend Yield of 0.46% is consistent with its peers in the Technology Hardware, Storage & Peripherals industry, providing a dividend return that is standard for its sector.
ABBV
3.11%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ABBV’s Dividend Yield of 3.11% is exceptionally high, placing it well above the typical range for the Biotechnology industry. While this may seem attractive, an unusually high yield can sometimes be a warning sign, reflecting a falling stock price or market concerns about the dividend’s sustainability.
Dividend Payout Ratio (TTM)
AAPL
15.47%
Technology Hardware, Storage & Peripherals Industry
- Max
- 142.87%
- Q3
- 66.07%
- Median
- 42.79%
- Q1
- 0.00%
- Min
- 0.00%
AAPL’s Dividend Payout Ratio of 15.47% is within the typical range for the Technology Hardware, Storage & Peripherals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
ABBV
226.84%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
At 226.84%, ABBV’s Dividend Payout Ratio is exceptionally high, exceeding the typical range for the Biotechnology industry. While this provides a significant return to shareholders, it may limit funds for reinvestment and could be difficult to sustain.
Dividend at a Glance
| Symbol | AAPL | ABBV |
|---|---|---|
| Dividend Yield (TTM) | 0.46% | 3.11% |
| Dividend Payout Ratio (TTM) | 15.47% | 226.84% |
Valuation
Price-to-Earnings Ratio (TTM)
AAPL
33.94
Technology Hardware, Storage & Peripherals Industry
- Max
- 43.16
- Q3
- 27.56
- Median
- 17.85
- Q1
- 12.48
- Min
- 6.21
A P/E Ratio of 33.94 places AAPL in the upper quartile for the Technology Hardware, Storage & Peripherals industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.
ABBV
96.80
Biotechnology Industry
- Max
- 60.14
- Q3
- 38.17
- Median
- 29.01
- Q1
- 15.12
- Min
- 0.00
At 96.80, ABBV’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Biotechnology industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.
Price-to-Sales Ratio (TTM)
AAPL
8.25
Technology Hardware, Storage & Peripherals Industry
- Max
- 4.27
- Q3
- 1.99
- Median
- 0.93
- Q1
- 0.45
- Min
- 0.04
With a P/S Ratio of 8.25, AAPL trades at a valuation that eclipses even the highest in the Technology Hardware, Storage & Peripherals industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.
ABBV
6.24
Biotechnology Industry
- Max
- 76.98
- Q3
- 36.53
- Median
- 9.49
- Q1
- 4.49
- Min
- 0.00
ABBV’s P/S Ratio of 6.24 aligns with the market consensus for the Biotechnology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
AAPL
46.55
Technology Hardware, Storage & Peripherals Industry
- Max
- 12.51
- Q3
- 6.11
- Median
- 1.73
- Q1
- 1.01
- Min
- 0.31
At 46.55, AAPL’s P/B Ratio is at an extreme premium to the Technology Hardware, Storage & Peripherals industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.
ABBV
261.01
Biotechnology Industry
- Max
- 20.53
- Q3
- 9.76
- Median
- 4.77
- Q1
- 2.49
- Min
- 0.59
At 261.01, ABBV’s P/B Ratio is at an extreme premium to the Biotechnology industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.
Valuation at a Glance
| Symbol | AAPL | ABBV |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 33.94 | 96.80 |
| Price-to-Sales Ratio (TTM) | 8.25 | 6.24 |
| Price-to-Book Ratio (MRQ) | 46.55 | 261.01 |
| Price-to-Free Cash Flow Ratio (TTM) | 35.03 | 19.97 |